Canopy Growth 2Q Loss Widens on U.S. Asset Charges

Dow Jones
11/06
 
 

Canopy Growth logged a wider loss in its fiscal second quarter, due to fair-value charges on its U.S. assets, overshadowing its international sales, which drove a surge in revenue.

For the three months ended Sept. 30, the cannabis company on Friday posted a widened net loss of 40.7 million Canadian dollars ($29 million), or C$0.10 a share, compared with a loss of C$5 million, or C$0.02 a share, in the comparable quarter a year ago.

The decline was largely due to C$35.8 million in fair value charges on the company's Canopy USA business and the assets related to it.

According to FactSet, analysts were expecting a loss of C$0.04 a share.

Consolidated revenue rose by 22% to C$81.4 million, but it was well below analyst forecasts of a greater rise to C$90.1 million.

Cannabis revenue rose 30% to C$66.2 million, thanks to gains in all three of its categories, medical, adult-use and international, the latter of which more than doubled its revenue in the quarter, led by strong medical sales in Germany and Poland.

Storz & Bickel, Canopy's vaporizer and device segment, slipped 4% to C$15.1 million, weighed down by softer consumer spending.

 
 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10